Author:
Fahrmann Johannes F.,Grapov Dmitry,Phinney Brett S.,Stroble Carol,DeFelice Brian C.,Rom William,Gandara David R.,Zhang Yanhong,Fiehn Oliver,Pass Harvey,Miyamoto Suzanne
Funder
LUNGevity and Thomas G. Labrecque Foundations award
National Institutes of Health
National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
Clinical Biochemistry,Molecular Biology,Molecular Medicine,Clinical Biochemistry,Molecular Biology,Molecular Medicine
Reference47 articles.
1. Prevention CfDCa. National Center for Health Statistics. CDC WONDER On-line Database, compiled from Compressed Mortality File 1999–2012; 2014, Series 20 No. 2R.
2. Society AC. Cancer facts and figures (
http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2014/index
). 2014. p. 1–60.
3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.
4. Breathnach OS, Freidlin B, Conley B, Green MR, Johnson DH, Gandara DR, O’Connell M, Shepherd FA, Johnson BE. Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results. J Clin Oncol. 2001;19:1734–42.
5. National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409.
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献